In Insulin Delivery Devices Market Syringes and Pumps to Contribute Over 50% Growth by 2021

Monday, June 27, 2016 Diabetes News J E 4

PUNE, India, June 27, 2016 /PRNewswire/ --

The new market report "Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021" has analyzed invasive devices market expected to reach US$10.4 billion by 2016 primarily supported by the segments Syringes, Pens, Pumps and Other. Globally, Syringes and Pumps together account for approximately more than 50% of the market and is expected that Insulin Delivery Devices industry to be going forward. Geographical analysis for Invasive Devices market shows that the highest Compounded Annual Growth Rate (CAGR) of 9.2% is anticipated from Asia-Pacific region during the analysis period, 2014-2021. Middle East follows Asia-Pacific with a CAGR of 8.6% while Africa forecasts to drive with a growth rate of 8.6%. As for Non-Invasive Devices the market is increasing at a Compound Annual Growth rate of 10.5% during the analysis period of 2014-2021.

Complete report Insulin Delivery Devices Market spread across 168 pages, analysing 40 companies and provides 95 data charts is now available at

The report "Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021" reviews the latest insulin market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.

The Insulin Delivery Devices Market report primarily focuses on: Emerging market trends; Advancements in the technological space; Market demand of the segments (by-region); Key growth areas and market size; Key competitor's Edge

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with insulin delivery devices market segment. Further, the subdivided categories include:

Invasive Devices:  Syringes, Pens (Reusable Cartridges and Disposable Cartridges), Pumps and Other*

Non-Invasive Devices: Inhalers, Patches, Sprays and Jet Injectors

* Other:  Softaware of Pumps, Smart Caps, Walet, Syringer Holders, Spring-Loaded Syringe Holders, Syringe Magnifiers and Light, Pen Needles

Order a Copy of Report at

The period considered for the insulin delivery devices market analysis is 2014-2021. The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 40 leading market players are identified and 20 key companies that project improved market activities in the near future are profiled. The report consists of 95 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the insulin deliver devices market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Key Companies profiled in Insulin Delivery Devices Market - Global Trends, Estimates and Forecasts, 2014-2021 report are Becton,  Dickinson And Company, B. Braun Melsungen Ag, Abbott Laboratories, Terumo Corporation, Medtronic,  Inc., Eli Lily And Company, Novo Nordisk, Sanofi-Aventis, F. Hoffmann-La Roche,  Ltd., Johnson & Johnson, Insulet Corporation, Valeritas, Tandem Diabetes Care,  Inc., Animas Corp., Sooil Development, Ambisea Technology, Owen Mumford,  Ltd., Htl-Strefa S.A, Allison Medical,  Inc., Ultimed,  Inc.

Another related report is "Insulin Market in the US and Europe 2016-2020". The analysts forecast insulin market in the US and Europe to grow at a CAGR of 6.17% during the period 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the branded drugs during the forecast period.

Key vendors: Sanofi, Novo Nordisk and Eli Lilly. Other prominent vendors: Adocia, Biocon, Biodel, Biogenomics, Boehringer Ingelheim, Dance Biopharm, Diasome Pharmaceuticals, Exsulin, Generex and more. Complete report is available at

Explore other reports on medical devices market at  

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune - 411013 Maharashtra, India. + 1 888 391 5441

Connect With Us on:



Twitter:  https: //

G+ / Google Plus:


SOURCE ReportsnReports



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
ADL Launches Revolutionary Urine-Based Diagnostic ...
Foot Wrap Offers Alternative to Medication for Pat...